🔗 Visit the ClinicalTrials.gov page for NCT02859142
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. | JAMA | 2006 | 10.31 |
| 2 | Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. | J Med Chem | 2005 | 6.13 |
| 3 | Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. | Science | 2004 | 5.94 |
| 4 | Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. | JAMA | 2014 | 1.11 |
| 5 | Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence. | Psychopharmacology (Berl) | 2010 | 0.89 |